Risk environments facing potential users of a supervised injection site in Ottawa, Canada

Supervised injection sites (SISs) have been effective in reducing health risks among people who inject drugs (PWID), including those who face issues of homelessness, mental health illness, interactions with local policing practices, and HIV infection. We investigate the risk behaviours and risk envi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Harm reduction journal 2015-10, Vol.12 (1), p.49-49, Article 49
Hauptverfasser: Shaw, Ashley, Lazarus, Lisa, Pantalone, Tyler, LeBlanc, Sean, Lin, Dolly, Stanley, Daina, Chepesiuk, Caleb, Patel, Sheetal, Tyndall, Mark
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 49
container_issue 1
container_start_page 49
container_title Harm reduction journal
container_volume 12
creator Shaw, Ashley
Lazarus, Lisa
Pantalone, Tyler
LeBlanc, Sean
Lin, Dolly
Stanley, Daina
Chepesiuk, Caleb
Patel, Sheetal
Tyndall, Mark
description Supervised injection sites (SISs) have been effective in reducing health risks among people who inject drugs (PWID), including those who face issues of homelessness, mental health illness, interactions with local policing practices, and HIV infection. We investigate the risk behaviours and risk environments currently faced by potential users of an SIS in Ottawa to establish the need for such a service and to contribute to the design of an SIS that can address current health risks and reduce harm. The PROUD cohort is a community-based participatory research (CBPR) project that examines the HIV risk environment among people who use drugs in Ottawa. From March to October 2013, 593 people who reported using injection drugs or smoking crack cocaine were enrolled through street-based recruitment in the ByWard Market neighbourhood, an area of the city with a high concentration of public drug use and homelessness. Participants completed a demographic, behavioural, and risk environment questionnaire and were offered HIV point-of-care testing. We undertook descriptive and univariate analyses to estimate potential use of an SIS by PWID in Ottawa and to explore risk behaviours and features of the risk environment faced by potential users of the service. Of those participants who reported injecting drugs in the previous 12 months (n = 270), 75.2 % (203) reported a willingness to use an SIS in Ottawa. Among potential SIS users, 24.6 % had recently injected with a used needle, 19.0 % had trouble accessing new needles, 60.6 % were unstably housed, 49.8 % had been redzoned by the police, and 12.8 % were HIV positive. Participants willing to use an SIS more frequently injected in public (OR = 1.98, 95 % CI = 1.06-3.70), required assistance to inject (OR = 1.84, 95 % CI = 1.00-3.38), were hepatitis C positive (OR = 2.13, 95 % CI = 1.16-3.91), had overdosed in the previous year (OR = 2.00, 95 % CI = 1.02-3.92), and identified as LGBTQ (OR = 5.61, 95 % CI = 1.30-24.19). An SIS in Ottawa would be well-positioned to reach its target group of highly marginalized PWID and reduce drug-related harms. The application of CBPR methods to a large-scale quantitative survey supported the mobilization of communities of PWID to identify and advocate for their own service needs, creating an enabling environment for harm reduction action.
doi_str_mv 10.1186/s12954-015-0083-9
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4618881</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A541504163</galeid><sourcerecordid>A541504163</sourcerecordid><originalsourceid>FETCH-LOGICAL-c522t-209b35cc18b4e17015f6a6b02f21180b693176b9342b24b03f9a9638ba6871e3</originalsourceid><addsrcrecordid>eNp9kk1rFTEUhgex2Fr9AW4k4MaFU3OSTD42Qrn4USgUpBtXIZObXHOdSa7JzBX_vRlurW2RkkVykue8OefwNs0rwGcAkr8vQFTHWgxdi7GkrXrSnAATohUdiKd3zsfN81K2GFecymfNMeFMUQrqpPn2NZQfyMV9yCmOLk4FeWND3KBdmmoYzIDm4nJBySODyrxzeR-KW6MQt85OIUVUwuRqiK6myfwy79DKRLM2L5ojb4biXt7sp831p4_Xqy_t5dXni9X5ZWs7QqaWYNXTzlqQPXMgai-eG95j4kntEfdcURC8V5SRnrAeU6-M4lT2hksBjp42Hw6yu7kf3drWmrMZ9C6H0eTfOpmg77_E8F1v0l4zDlJKqAJvbwRy-jm7MukxFOuGwUSX5qJBEMG7jhFZ0TcP0G2ac6zdaYoVBiIJVY9RIIQSVZDSf9TGDE6H6FOtzi5f6_OOQYcZ8IU6-w9V19qNwabofKj39xLgkGBzKiU7fzsJwHoxjT6YRtdB68U0ein49d0R3mb8dQn9A6WGujw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779717233</pqid></control><display><type>article</type><title>Risk environments facing potential users of a supervised injection site in Ottawa, Canada</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>SpringerNature Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Shaw, Ashley ; Lazarus, Lisa ; Pantalone, Tyler ; LeBlanc, Sean ; Lin, Dolly ; Stanley, Daina ; Chepesiuk, Caleb ; Patel, Sheetal ; Tyndall, Mark</creator><creatorcontrib>Shaw, Ashley ; Lazarus, Lisa ; Pantalone, Tyler ; LeBlanc, Sean ; Lin, Dolly ; Stanley, Daina ; Chepesiuk, Caleb ; Patel, Sheetal ; Tyndall, Mark ; PROUD Community Advisory Committee ; The PROUD Community Advisory Committee</creatorcontrib><description>Supervised injection sites (SISs) have been effective in reducing health risks among people who inject drugs (PWID), including those who face issues of homelessness, mental health illness, interactions with local policing practices, and HIV infection. We investigate the risk behaviours and risk environments currently faced by potential users of an SIS in Ottawa to establish the need for such a service and to contribute to the design of an SIS that can address current health risks and reduce harm. The PROUD cohort is a community-based participatory research (CBPR) project that examines the HIV risk environment among people who use drugs in Ottawa. From March to October 2013, 593 people who reported using injection drugs or smoking crack cocaine were enrolled through street-based recruitment in the ByWard Market neighbourhood, an area of the city with a high concentration of public drug use and homelessness. Participants completed a demographic, behavioural, and risk environment questionnaire and were offered HIV point-of-care testing. We undertook descriptive and univariate analyses to estimate potential use of an SIS by PWID in Ottawa and to explore risk behaviours and features of the risk environment faced by potential users of the service. Of those participants who reported injecting drugs in the previous 12 months (n = 270), 75.2 % (203) reported a willingness to use an SIS in Ottawa. Among potential SIS users, 24.6 % had recently injected with a used needle, 19.0 % had trouble accessing new needles, 60.6 % were unstably housed, 49.8 % had been redzoned by the police, and 12.8 % were HIV positive. Participants willing to use an SIS more frequently injected in public (OR = 1.98, 95 % CI = 1.06-3.70), required assistance to inject (OR = 1.84, 95 % CI = 1.00-3.38), were hepatitis C positive (OR = 2.13, 95 % CI = 1.16-3.91), had overdosed in the previous year (OR = 2.00, 95 % CI = 1.02-3.92), and identified as LGBTQ (OR = 5.61, 95 % CI = 1.30-24.19). An SIS in Ottawa would be well-positioned to reach its target group of highly marginalized PWID and reduce drug-related harms. The application of CBPR methods to a large-scale quantitative survey supported the mobilization of communities of PWID to identify and advocate for their own service needs, creating an enabling environment for harm reduction action.</description><identifier>ISSN: 1477-7517</identifier><identifier>EISSN: 1477-7517</identifier><identifier>DOI: 10.1186/s12954-015-0083-9</identifier><identifier>PMID: 26493319</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adult ; Canada ; Cocaine ; Cohort Studies ; Community involvement ; Community-Based Participatory Research - methods ; Complications and side effects ; Crack (Drug) ; Data collection ; Development and progression ; Drug abuse ; Drug development ; Drug therapy ; Drug use ; Drugs ; Female ; Harm Reduction ; Health aspects ; Health risks ; Hepatitis C ; HIV ; HIV infection ; HIV Infections - etiology ; HIV Infections - prevention &amp; control ; Homeless people ; Homeless Persons - statistics &amp; numerical data ; Homelessness ; Human immunodeficiency virus ; Humans ; Infection ; Injection ; Male ; Medical research ; Medical students ; Medicine, Experimental ; Mental disorders ; Mental health ; Needle-Exchange Programs - methods ; Needle-Exchange Programs - statistics &amp; numerical data ; Participatory research ; Patient outcomes ; Pharmaceutical industry ; Police ; Risk analysis ; Risk Factors ; Risk taking ; Service design ; Substance Abuse, Intravenous - complications ; Surveys and Questionnaires</subject><ispartof>Harm reduction journal, 2015-10, Vol.12 (1), p.49-49, Article 49</ispartof><rights>COPYRIGHT 2015 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2015</rights><rights>2015. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Shaw et al. 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c522t-209b35cc18b4e17015f6a6b02f21180b693176b9342b24b03f9a9638ba6871e3</citedby><cites>FETCH-LOGICAL-c522t-209b35cc18b4e17015f6a6b02f21180b693176b9342b24b03f9a9638ba6871e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618881/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618881/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26493319$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shaw, Ashley</creatorcontrib><creatorcontrib>Lazarus, Lisa</creatorcontrib><creatorcontrib>Pantalone, Tyler</creatorcontrib><creatorcontrib>LeBlanc, Sean</creatorcontrib><creatorcontrib>Lin, Dolly</creatorcontrib><creatorcontrib>Stanley, Daina</creatorcontrib><creatorcontrib>Chepesiuk, Caleb</creatorcontrib><creatorcontrib>Patel, Sheetal</creatorcontrib><creatorcontrib>Tyndall, Mark</creatorcontrib><creatorcontrib>PROUD Community Advisory Committee</creatorcontrib><creatorcontrib>The PROUD Community Advisory Committee</creatorcontrib><title>Risk environments facing potential users of a supervised injection site in Ottawa, Canada</title><title>Harm reduction journal</title><addtitle>Harm Reduct J</addtitle><description>Supervised injection sites (SISs) have been effective in reducing health risks among people who inject drugs (PWID), including those who face issues of homelessness, mental health illness, interactions with local policing practices, and HIV infection. We investigate the risk behaviours and risk environments currently faced by potential users of an SIS in Ottawa to establish the need for such a service and to contribute to the design of an SIS that can address current health risks and reduce harm. The PROUD cohort is a community-based participatory research (CBPR) project that examines the HIV risk environment among people who use drugs in Ottawa. From March to October 2013, 593 people who reported using injection drugs or smoking crack cocaine were enrolled through street-based recruitment in the ByWard Market neighbourhood, an area of the city with a high concentration of public drug use and homelessness. Participants completed a demographic, behavioural, and risk environment questionnaire and were offered HIV point-of-care testing. We undertook descriptive and univariate analyses to estimate potential use of an SIS by PWID in Ottawa and to explore risk behaviours and features of the risk environment faced by potential users of the service. Of those participants who reported injecting drugs in the previous 12 months (n = 270), 75.2 % (203) reported a willingness to use an SIS in Ottawa. Among potential SIS users, 24.6 % had recently injected with a used needle, 19.0 % had trouble accessing new needles, 60.6 % were unstably housed, 49.8 % had been redzoned by the police, and 12.8 % were HIV positive. Participants willing to use an SIS more frequently injected in public (OR = 1.98, 95 % CI = 1.06-3.70), required assistance to inject (OR = 1.84, 95 % CI = 1.00-3.38), were hepatitis C positive (OR = 2.13, 95 % CI = 1.16-3.91), had overdosed in the previous year (OR = 2.00, 95 % CI = 1.02-3.92), and identified as LGBTQ (OR = 5.61, 95 % CI = 1.30-24.19). An SIS in Ottawa would be well-positioned to reach its target group of highly marginalized PWID and reduce drug-related harms. The application of CBPR methods to a large-scale quantitative survey supported the mobilization of communities of PWID to identify and advocate for their own service needs, creating an enabling environment for harm reduction action.</description><subject>Adult</subject><subject>Canada</subject><subject>Cocaine</subject><subject>Cohort Studies</subject><subject>Community involvement</subject><subject>Community-Based Participatory Research - methods</subject><subject>Complications and side effects</subject><subject>Crack (Drug)</subject><subject>Data collection</subject><subject>Development and progression</subject><subject>Drug abuse</subject><subject>Drug development</subject><subject>Drug therapy</subject><subject>Drug use</subject><subject>Drugs</subject><subject>Female</subject><subject>Harm Reduction</subject><subject>Health aspects</subject><subject>Health risks</subject><subject>Hepatitis C</subject><subject>HIV</subject><subject>HIV infection</subject><subject>HIV Infections - etiology</subject><subject>HIV Infections - prevention &amp; control</subject><subject>Homeless people</subject><subject>Homeless Persons - statistics &amp; numerical data</subject><subject>Homelessness</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infection</subject><subject>Injection</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical students</subject><subject>Medicine, Experimental</subject><subject>Mental disorders</subject><subject>Mental health</subject><subject>Needle-Exchange Programs - methods</subject><subject>Needle-Exchange Programs - statistics &amp; numerical data</subject><subject>Participatory research</subject><subject>Patient outcomes</subject><subject>Pharmaceutical industry</subject><subject>Police</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>Risk taking</subject><subject>Service design</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Surveys and Questionnaires</subject><issn>1477-7517</issn><issn>1477-7517</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kk1rFTEUhgex2Fr9AW4k4MaFU3OSTD42Qrn4USgUpBtXIZObXHOdSa7JzBX_vRlurW2RkkVykue8OefwNs0rwGcAkr8vQFTHWgxdi7GkrXrSnAATohUdiKd3zsfN81K2GFecymfNMeFMUQrqpPn2NZQfyMV9yCmOLk4FeWND3KBdmmoYzIDm4nJBySODyrxzeR-KW6MQt85OIUVUwuRqiK6myfwy79DKRLM2L5ojb4biXt7sp831p4_Xqy_t5dXni9X5ZWs7QqaWYNXTzlqQPXMgai-eG95j4kntEfdcURC8V5SRnrAeU6-M4lT2hksBjp42Hw6yu7kf3drWmrMZ9C6H0eTfOpmg77_E8F1v0l4zDlJKqAJvbwRy-jm7MukxFOuGwUSX5qJBEMG7jhFZ0TcP0G2ac6zdaYoVBiIJVY9RIIQSVZDSf9TGDE6H6FOtzi5f6_OOQYcZ8IU6-w9V19qNwabofKj39xLgkGBzKiU7fzsJwHoxjT6YRtdB68U0ein49d0R3mb8dQn9A6WGujw</recordid><startdate>20151022</startdate><enddate>20151022</enddate><creator>Shaw, Ashley</creator><creator>Lazarus, Lisa</creator><creator>Pantalone, Tyler</creator><creator>LeBlanc, Sean</creator><creator>Lin, Dolly</creator><creator>Stanley, Daina</creator><creator>Chepesiuk, Caleb</creator><creator>Patel, Sheetal</creator><creator>Tyndall, Mark</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYCSY</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151022</creationdate><title>Risk environments facing potential users of a supervised injection site in Ottawa, Canada</title><author>Shaw, Ashley ; Lazarus, Lisa ; Pantalone, Tyler ; LeBlanc, Sean ; Lin, Dolly ; Stanley, Daina ; Chepesiuk, Caleb ; Patel, Sheetal ; Tyndall, Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c522t-209b35cc18b4e17015f6a6b02f21180b693176b9342b24b03f9a9638ba6871e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Canada</topic><topic>Cocaine</topic><topic>Cohort Studies</topic><topic>Community involvement</topic><topic>Community-Based Participatory Research - methods</topic><topic>Complications and side effects</topic><topic>Crack (Drug)</topic><topic>Data collection</topic><topic>Development and progression</topic><topic>Drug abuse</topic><topic>Drug development</topic><topic>Drug therapy</topic><topic>Drug use</topic><topic>Drugs</topic><topic>Female</topic><topic>Harm Reduction</topic><topic>Health aspects</topic><topic>Health risks</topic><topic>Hepatitis C</topic><topic>HIV</topic><topic>HIV infection</topic><topic>HIV Infections - etiology</topic><topic>HIV Infections - prevention &amp; control</topic><topic>Homeless people</topic><topic>Homeless Persons - statistics &amp; numerical data</topic><topic>Homelessness</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infection</topic><topic>Injection</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical students</topic><topic>Medicine, Experimental</topic><topic>Mental disorders</topic><topic>Mental health</topic><topic>Needle-Exchange Programs - methods</topic><topic>Needle-Exchange Programs - statistics &amp; numerical data</topic><topic>Participatory research</topic><topic>Patient outcomes</topic><topic>Pharmaceutical industry</topic><topic>Police</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>Risk taking</topic><topic>Service design</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shaw, Ashley</creatorcontrib><creatorcontrib>Lazarus, Lisa</creatorcontrib><creatorcontrib>Pantalone, Tyler</creatorcontrib><creatorcontrib>LeBlanc, Sean</creatorcontrib><creatorcontrib>Lin, Dolly</creatorcontrib><creatorcontrib>Stanley, Daina</creatorcontrib><creatorcontrib>Chepesiuk, Caleb</creatorcontrib><creatorcontrib>Patel, Sheetal</creatorcontrib><creatorcontrib>Tyndall, Mark</creatorcontrib><creatorcontrib>PROUD Community Advisory Committee</creatorcontrib><creatorcontrib>The PROUD Community Advisory Committee</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Environmental Science Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Environmental Science Collection</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Harm reduction journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shaw, Ashley</au><au>Lazarus, Lisa</au><au>Pantalone, Tyler</au><au>LeBlanc, Sean</au><au>Lin, Dolly</au><au>Stanley, Daina</au><au>Chepesiuk, Caleb</au><au>Patel, Sheetal</au><au>Tyndall, Mark</au><aucorp>PROUD Community Advisory Committee</aucorp><aucorp>The PROUD Community Advisory Committee</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk environments facing potential users of a supervised injection site in Ottawa, Canada</atitle><jtitle>Harm reduction journal</jtitle><addtitle>Harm Reduct J</addtitle><date>2015-10-22</date><risdate>2015</risdate><volume>12</volume><issue>1</issue><spage>49</spage><epage>49</epage><pages>49-49</pages><artnum>49</artnum><issn>1477-7517</issn><eissn>1477-7517</eissn><abstract>Supervised injection sites (SISs) have been effective in reducing health risks among people who inject drugs (PWID), including those who face issues of homelessness, mental health illness, interactions with local policing practices, and HIV infection. We investigate the risk behaviours and risk environments currently faced by potential users of an SIS in Ottawa to establish the need for such a service and to contribute to the design of an SIS that can address current health risks and reduce harm. The PROUD cohort is a community-based participatory research (CBPR) project that examines the HIV risk environment among people who use drugs in Ottawa. From March to October 2013, 593 people who reported using injection drugs or smoking crack cocaine were enrolled through street-based recruitment in the ByWard Market neighbourhood, an area of the city with a high concentration of public drug use and homelessness. Participants completed a demographic, behavioural, and risk environment questionnaire and were offered HIV point-of-care testing. We undertook descriptive and univariate analyses to estimate potential use of an SIS by PWID in Ottawa and to explore risk behaviours and features of the risk environment faced by potential users of the service. Of those participants who reported injecting drugs in the previous 12 months (n = 270), 75.2 % (203) reported a willingness to use an SIS in Ottawa. Among potential SIS users, 24.6 % had recently injected with a used needle, 19.0 % had trouble accessing new needles, 60.6 % were unstably housed, 49.8 % had been redzoned by the police, and 12.8 % were HIV positive. Participants willing to use an SIS more frequently injected in public (OR = 1.98, 95 % CI = 1.06-3.70), required assistance to inject (OR = 1.84, 95 % CI = 1.00-3.38), were hepatitis C positive (OR = 2.13, 95 % CI = 1.16-3.91), had overdosed in the previous year (OR = 2.00, 95 % CI = 1.02-3.92), and identified as LGBTQ (OR = 5.61, 95 % CI = 1.30-24.19). An SIS in Ottawa would be well-positioned to reach its target group of highly marginalized PWID and reduce drug-related harms. The application of CBPR methods to a large-scale quantitative survey supported the mobilization of communities of PWID to identify and advocate for their own service needs, creating an enabling environment for harm reduction action.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>26493319</pmid><doi>10.1186/s12954-015-0083-9</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1477-7517
ispartof Harm reduction journal, 2015-10, Vol.12 (1), p.49-49, Article 49
issn 1477-7517
1477-7517
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4618881
source MEDLINE; DOAJ Directory of Open Access Journals; SpringerNature Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adult
Canada
Cocaine
Cohort Studies
Community involvement
Community-Based Participatory Research - methods
Complications and side effects
Crack (Drug)
Data collection
Development and progression
Drug abuse
Drug development
Drug therapy
Drug use
Drugs
Female
Harm Reduction
Health aspects
Health risks
Hepatitis C
HIV
HIV infection
HIV Infections - etiology
HIV Infections - prevention & control
Homeless people
Homeless Persons - statistics & numerical data
Homelessness
Human immunodeficiency virus
Humans
Infection
Injection
Male
Medical research
Medical students
Medicine, Experimental
Mental disorders
Mental health
Needle-Exchange Programs - methods
Needle-Exchange Programs - statistics & numerical data
Participatory research
Patient outcomes
Pharmaceutical industry
Police
Risk analysis
Risk Factors
Risk taking
Service design
Substance Abuse, Intravenous - complications
Surveys and Questionnaires
title Risk environments facing potential users of a supervised injection site in Ottawa, Canada
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T02%3A38%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20environments%20facing%20potential%20users%20of%20a%20supervised%20injection%20site%20in%20Ottawa,%20Canada&rft.jtitle=Harm%20reduction%20journal&rft.au=Shaw,%20Ashley&rft.aucorp=PROUD%20Community%20Advisory%20Committee&rft.date=2015-10-22&rft.volume=12&rft.issue=1&rft.spage=49&rft.epage=49&rft.pages=49-49&rft.artnum=49&rft.issn=1477-7517&rft.eissn=1477-7517&rft_id=info:doi/10.1186/s12954-015-0083-9&rft_dat=%3Cgale_pubme%3EA541504163%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1779717233&rft_id=info:pmid/26493319&rft_galeid=A541504163&rfr_iscdi=true